| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 606,708 | 623,334 | 589,848 | | Cost of Revenue | 433,007 | 438,781 | 425,248 | | | Gross Profit | 173,701 | 184,553 | 164,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 110,341 | 109,602 | 95,828 | | Non Recurring | 108,921 | 3,688 | 133 | | Others | 998 | 115 | 183 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (46,559) | 71,148 | 68,456 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,606 | 3,012 | 1,894 | | Earnings Before Interest And Taxes | (44,953) | 74,160 | 70,350 | | Interest Expense | 13,148 | 14,629 | 16,430 | | Income Before Tax | (58,101) | 59,531 | 53,920 | | Income Tax Expense | 18,001 | 22,739 | 20,539 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (76,102) | 36,792 | 33,381 | | | Non-recurring Events | | Discontinued Operations | (2,282) | 557 | 704 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (78,384) | 37,349 | 34,085 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($78,384) | $37,349 | $34,085 |
|
0.25% Nasdaq 
Income Statement
